A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites

Journal of Nuclear Medicine

Volumn 37, Issue 12, 1996, Pages 2049-2057

  Mankoff, David A ^a   Shields, Anthony F ^b   Graham, Michael M ^b   Link, Jeanne M ^b   Krohn, Kenneth A ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b NONE

Author keywords

carbon 11 thymidine; metabolites; modeling; PET

Indexed keywords

CARBON 11; DRUG METABOLITE; THYMIDINE; TRACER;

ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; COMPUTER SIMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TISSUE LEVEL; HUMAN; IMAGE ANALYSIS; MATHEMATICAL MODEL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CARBON RADIOISOTOPES; COMPUTER SIMULATION; DNA; RADIOPHARMACEUTICALS; THYMIDINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030482685     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
2. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations J Cereb Blood Flow Metab 1985;5: 584-590.
3. Gjedde A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res Rev 1982;4:237-274.
4. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
5. 18F-2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-388.
6. 11C]deoxyglucose. J Cereb Blood Flow Metabol 1985;5:179-192.
7. Martin WRW, Palmer MR, Patlak CS, Calne DB, Nigrostriatal function in humans studies with PET. Ann Neurol 1989;26:535-542.
8. Patlak C, Dhawan V, Takikawa S, et al. Estimation of striatal uptake rate constant of FDOPA using PET: methodologic issues. In: Uemura K, Lassen NA, Kanno I, eds. Quantification of brain Junction. Tracer kinetica and image analysis in brain PET. Amsterdam, the Netherlands: Elsevier Science Publishers; 1993:263-268.
9. 11C]-tyrosine and PET. J Nucl Med 1995;36:411-419.
10. Shields AF, Lim K, Grierson J, et al. Utilization of labeled thymidinc in DNA synthesis: studies for PET. J Nucl Med 1990;31:337-42.
11. 11C]thymidine and PET [Abstract]. J Nucl Med 1994;35(suppl):138P.
12. 18F]fluoro-DOPA in human PET studies. J Cereb Blood Flow Metab 1991;11:898-913.
13. 11C]thymidine for quantification of cellular proliferation with PET. Appl Radiat Isotopes 1991;42: 103-104.
14. Vander Borght T, Lambette L, Pauwels S, et al. Uptake of thymidine labeled on carbon 2: a potential indicator of liver regeneration by PET. Hepatology 1991;12:113-118.
15. Shields AF, Coonrod DV, Quackenbush RC, Crowley JJ. Cellular sources of thymidine nucleotides: studies for PET. J Nucl Med 1987;28:1435-1440.
16. Cleaver JE. Thymidine metabolism and cell kinetics. Frontiers Biol 1967;6:43-100.
17. Martial P, Ferrant A, Labar D. In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using PET. J Nucl Med 1988;29:1633-1637.
18. Shields AF, Graham MM, Kozawa SM, et al. Contribution of labeled carbon dioxide to PET imaging of carbon-11-labeled compounds. J Nucl Med 1992;33:581-4.
19. 2 and PET. J Cereb Blood Flow Metab 1984;4:458-465.
20. 2 and PET. J Cereb Blood Flow Metab 1984;4:8-16.
21. Hetenyi Jr G, Lussier B, Ferrarotto Jr C. Calculation of the rate of gluconeogenesis from the incorporation of C-14 atoms from labeled bicarbonate or acetate. Can J Physiol Pharmacol 1982;60:1603-1609.
22. - from blood to brain. J Appl Physiol 1983;54:989-996.
23. 2 into the acid-labile, the acid-soluble, the lipid, the protein and the nucleic acid fractions of rat brain tissue. Acta Physiol Scand 1965;64:182-192.
24. 11C]-carbon dioxide fixation and equilibration in rat brain: effects on acid-base measurements. Neurology 1982;32:451-454.
25. Covey JM, Straw JA. Nonlinear pharmacokinetios of thymidine, thymine and fluorouracil and their kinetic interactions in dogs. Cancer Res 1983;43:4587-4595.
26. Goldman D, Bowen D, Gewirtz DA. Some considerations in the experimental approach to distinguishing between membrane transport and intracellular disposition of antineoplastic agents, with specific reference to fluorodeoxyuridine. actinomycin D and methotrexate. Cancer Treatment Rep 1981;65:43-56.
27. Kuebbing D, Werner R. A model for compartmentation of de novo and salvage thymidine nucleotide pools in mammalian cells. Proc Natl Acad Sci 1975;72:3333-3336.
28. Taheri MR, Wickermasingthe RG, Hoffbrand AV. Alternative metabolic fates of thymine nuclcotides in human cells. Biochem J 1981;194:451-461.
29. Tew KD, Taylor DM. The relationship of thymidine metabolism to the use of fractional incorporation as a measure of DNA synthesis in tissue proliferation. Eur J Cancer 1978;14:153-168.
30. Wohlhueter RM, Marz R, Plagemann PGW. Thymidine transport in cultured mammalian cells, kinetic analysis, temperature dependence and specificity of the transport system. Biochim Biophys Acta 1979;553:262-283
31. Yalowich JC, Goldman ID. Analysis of the inhibitory effects of VP-16-213 (etoposide) and podophyllotoxin on thymidine transport and metabolism in Ehrlich ascites tumor cells in vitro. Cancer Res 1984;44:984-989.
32. Graham MM. Parameter optimization programs for PET data analysis. J Nucl Med 1992;33:1069.
33. Courter JH, Link JM, Krohn KA. Automation of the synthesis of [2-carbon-11]thymidine. In: Weinrich R, ed. Proceedings of the 4th Workshop on Targetry and Target Chemistry. Villigen, Switzerland: Paul Scherer Institute; 1992:210-214.
34. Press W, Flannery B, Teukolsky S, Vetterling WT. Numerical recipes in C. New York, NY: Cambridge University Press: 1988.
35. Molnar P, Groothius D, Blasberg R. et al. Regional thymidine transport and incorporation in experimental brain and subcutaneous tumors. J Neurochem 1984;43: 421-432.